Tags: biotechnologyCRISPRdrug developmentDrug pricesgene editing
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | More beef in the gene editing space - 1 day ago How resurrecting extinct species might impact medicine - 8 months ago What happens when an approved drug doesn’t work? - 8 months ago Regeneron gene therapy improves hearing in child - about 1 year ago | |
| 2 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 3 | Jesse Klein GreenBiz Comedian. Woodsman. | ||
| 4 | Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto | CRISPR Gene Drives and the Future of Evolution - 8 months ago | |
| 5 | <em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. | Epigenetics in a Dish - 9 months ago | |
| 6 | Andrew Paul Popular Science Now on Bluesky America's Heartland | ||
| 7 | Danielle Gerhard, PhD The Scientist Assistant Editor @TheScientistLLC. United Kingdom | All Roads Lead to Genome Editing - 10 months ago All Roads Lead to Genome Editing - 10 months ago | |
| 8 | <em>The Scientist</em>’s Creative Services Team The Scientist Exploring Life, Inspiring Innovation. | Optimizing Gene Editing with PARP1 CRISPR Plasmids - 10 months ago | |
| 9 | Jason Mast STAT News Writing about science, medicine. | STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution - 11 months ago | |
| 10 | Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. |